Document Details
Form
Filing Date
Apr 01, 2019
Document Date
Mar 29, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
LURKER NANCY
